While AI continues to dominate headlines, Biotechnology is quietly becoming one of the strongest sectors in the market.
Top 15 Biotechnology Stocks to Watch:
$VRTX – Leader in cystic fibrosis treatments and expanding into gene-editing and rare diseases.
$RVMD – Focused on precision oncology targeting RAS-driven cancers.
$CRSP – Pioneer in gene-editing with approved and pipeline therapies.
$NTLA – Developing in-vivo gene-editing treatments with breakthrough potential.
$ABCL – AI-powered antibody discovery platform for drug development.
$RXRX – Uses AI and automation to accelerate drug discovery at scale.
$BEAM – Specializes in base-editing gene technology for precise DNA correction.
$XENE – Focused on neurology and epilepsy-related treatments.
$GH – Leader in liquid biopsy cancer diagnostics and early detection.
$TWST – Produces synthetic DNA used in genomics and biotech research.
$CGON – Developing immunotherapy treatments for bladder cancer and oncology.
$DNLI – Focused on neurodegenerative diseases like Alzheimer’s and Parkinson’s.
$IMVT – Developing therapies for autoimmune diseases using antibody technology.
$ARWR – RNA interference platform targeting genetic and chronic diseases.
$KRYS – Commercial-stage gene therapy company focused on rare skin disorders.
These names represent the frontier of modern medicine where genetics, AI, and precision therapies are converging. As capital rotates beyond AI infrastructure, biotech is shaping up as one of the most compelling long-term opportunity sectors.
